ADI (Biotechnology) Overview
Latest Deal Type
Series B
Latest Deal Amount
$1.68M
ADI (Biotechnology) General Information
Description
Developer of a bio dynamic imaging platform intended to deliver drug assessment in three-dimensional (3D) living tissue samples. The company's platform develops a biodynamic imaging technology that helps in phenotype drug response mapping in tumor tissue of chemotherapy and detection of diverse cellular motions inside living tissue, enabling researchers to convert all forms of functional cellular motions into contrast maps of cellular mechanisms of action.
ADI (Biotechnology) Timeline
Want to dig into this profile?
We’ll help you find what you need
Learn more
ADI (Biotechnology) Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 6. Early Stage VC (Series B) |
29-Jun-2018 |
$1.68M |
00.000 |
|
Completed |
Generating Revenue |
| 5. Early Stage VC (Series A) |
13-Jun-2016 |
00.00 |
00.00 |
|
Completed |
Generating Revenue |
| 4. Grant |
29-Oct-2015 |
0000 |
|
|
Completed |
Generating Revenue |
| 3. Grant |
21-Aug-2015 |
00000 |
|
|
Completed |
Generating Revenue |
| 2. Accelerator/Incubator |
01-Jan-2014 |
|
|
|
Completed |
Generating Revenue |
| 1. Grant |
01-Jan-2014 |
|
|
|
Completed |
Generating Revenue |
ADI (Biotechnology) Executive Team (7)
| Name |
Title |
Board Seat |
Contact Info |
| Theodore Schenberg |
Chief Executive Officer & Board Member |
|
|
| Travis Morgan |
Chief Operating and Financial Officer & Board Member |
|
|
| David Nolte Ph.D |
Co-Founder, Chief Scientific Officer & Board Member |
|
|
| Ran An Ph.D |
Chief Technical Officer and Co-founder |
|
|
| John Turek Ph.D |
Co-Founder, Vice President & Board Member |
|
|
ADI (Biotechnology) Board Members (4)
| Name |
Representing |
Role |
Since |
| David Nolte Ph.D |
ADI (Biotechnology) |
Co-Founder, Chief Scientific Officer & Board Member |
000 0000
|
| John Turek Ph.D |
ADI (Biotechnology) |
Co-Founder, Vice President & Board Member |
000 0000
|
| Theodore Schenberg |
ADI (Biotechnology) |
Chief Executive Officer & Board Member |
000 0000
|
| Travis Morgan |
ADI (Biotechnology) |
Chief Operating and Financial Officer & Board Member |
000 0000
|